诊断影像市场 - 全球产业规模、份额、趋势、机会及预测（按产品、应用、最终用途、地区和竞争格局划分），2021-2031年

全球诊断影像市场预计将从 2025 年的 281.2 亿美元成长到 2031 年的 378.8 亿美元，复合年增长率为 5.09%。

该领域涵盖多种医疗技术，例如X光、磁振造影（MRI）、电脑断层扫描（CT）和超音波，这些技术能够可视化体内生理结构，对诊断和监测健康状况至关重要。市场成长的主要驱动力是人口结构变化，特别是全球人口快速老化以及心血管疾病和癌症等慢性病的日益增加。这些因素使得频繁的诊断干预和疾病早期检测变得尤为必要，从而为市场扩张奠定了坚实的基础，使其超越了短暂的技术趋势。

然而，由于全球训练有素的技术人员和放射科医生严重短缺，市场面临着巨大的扩充性障碍，这限制了医疗系统应对日益增长的检查量的能力。这种人才短缺正在造成严重的瓶颈和患者照护延误。例如，英国英国放射学院报告称，到2024年，临床放射科医生将出现29%的缺口，因为对CT和MRI等复杂扫描的需求增加了8%，而顾问医生的数量仅增加了4.7%。

市场驱动因素

将人工智慧 (AI) 和机器学习 (ML) 整合到诊断成像工作流程中，正透过提高诊断准确性和营运效率，彻底改变全球诊断成像市场。这些技术透过自动化常规影像分析、优化扫描通讯协定以及优先审查急诊病例，在缓解实验室资源短缺方面发挥至关重要的作用。这些先进演算法的监管核准正在加速推进。根据美国食品药物管理局(FDA) 预测，截至 2024 年 8 月，累计核准的AI 和机器学习医疗设备数量将达到 950 种，其中放射学应用占总核准的 76%。透过简化工作流程和缩短扫描时间，AI 的整合提高了患者吞吐量，并最大限度地发挥了现有诊断成像基础设施的效用。

疫情过后，各国政府和私人机构加大对医疗基础设施的投资，以应对检测延误併升级老旧设施，进一步推动了市场成长。公共部门正投入大量资金采购先进的诊断工具，分散医疗服务，提高医疗服务的可近性。例如，英国政府在2024年10月的秋季预算中拨款15亿英镑用于扩大诊断能力，推动引进尖端扫描器和建立新的外科中心。这些投资为主要行业参与者带来了强劲的财务表现。 2024年11月，西门子医疗公布其诊断影像部门的销售额年增7.7%，凸显了全球对先进诊断系统的持续需求。

市场挑战

训练有素的放射科医生和技术人员短缺是限制全球诊断影像市场规模发展的结构性障碍。儘管慢性病盛行率的上升理论上会增加检查量的需求，但由于缺乏专业人员，医疗机构无法将这种需求完全转化为市场成长。如果没有合格的人员操作和解读结果，诊断设备就无法发挥作用，从而有效地限制了营运效率。因此，医疗机构被迫推迟新技术的应用，并将资本预算用于支付高成本的人事费用，而不是扩大诊断能力。

这种营运负担造成了系统性效率低下，严重阻碍了市场发展。 2024年，英国英国放射学院指出，97%的放射科被迫依赖昂贵的外包或内部解决方案来应对难以承受的检测结果报告工作量。这种对外部支援的过度依赖表明，现有人员配置已达到饱和点，无法支撑内部成长。由于医疗系统难以应对这些瓶颈，新增诊断影像基础设施的采用停滞不前，直接阻碍了市场更广泛的扩张潜力。

市场趋势

随着磁振造影（MRI）和电脑断层扫描（CT）等高能耗成像方式对环境的影响日益凸显，永续且环保的诊断影像解决方案正成为市场关注的焦点。製造商正在开发能够最大限度降低电力消耗并减少对稀缺资源（例如用于冷却传统磁铁的氦气）依赖的系统。这种转变正在监管和营运层面同时发生，医疗机构力求降低长期营运成本并为供应链波动做好准备。根据皇家飞利浦公司2025年3月发布的报告，自2018年以来，其BlueSeal磁铁技术已累积节省超过275万升氦气，显示无氦基础设施正在迅速普及。

同时，携带式和照护现场设备的普及正在使诊断服务更加大众化，并将诊断影像的应用范围从传统医院扩展到各种临床环境。半导体技术的进步使得手持式超音波设备得以开发，其体积和成本仅为传统推车式系统的几分之一，却能提供高解析度影像。这一趋势有助于在床边进行即时诊断，缩短患者等待时间，并减轻中心放射科的负担。 2025年5月，Butterfly Networks公布的第一季财报显示，其营收年增20%，这印证了全球对高度携带式诊断成像解决方案日益增长的需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球诊断影像市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（X光、超音波、电脑断层扫描、核子医学扫描术诊断、磁振造影造影）
  • 依应用领域（肿瘤科、神经科、心臟科、妇科、整形外科等）
  • 依最终用户（医院、诊断影像中心、门诊影像中心）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美诊断影像市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲诊断影像市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区诊断影像市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲诊断影像市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲诊断影像市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球诊断影像市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• GE HealthCare Technologies Inc.
• Koninklijke Philips NV
• Hitachi High-Tech Corporation
• Hologic, Inc.
• Siemens Healthineers AG
• Samsung Medicine Co., Ltd.
• Shimadzu Corporation
• Toshiba Medical Systems Corporation
• Esaote SpA
• Fujifilm Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Diagnostic Imaging Market is projected to expand from USD 28.12 Billion in 2025 to USD 37.88 Billion by 2031, reflecting a compound annual growth rate of 5.09%. This sector encompasses a variety of medical technologies, including X-ray, magnetic resonance imaging, computed tomography, and ultrasound, which are essential for visualizing internal physiological structures to diagnose and monitor health conditions. The market's growth is fundamentally driven by demographic changes, particularly a rapidly aging global population and the increasing prevalence of chronic diseases such as cardiovascular disorders and cancer. These factors necessitate frequent diagnostic interventions and early disease detection, establishing a solid foundation for market expansion that extends beyond temporary technological trends.

However, the market faces a significant scalability hurdle due to a critical global shortage of trained technicians and radiologists, which limits the capacity of healthcare systems to handle rising procedural volumes. This workforce deficit causes severe bottlenecks and delays in patient care. For instance, the Royal College of Radiologists reported in 2024 that the clinical radiology workforce operated with a 29% shortfall, as the demand for complex scans like CT and MRI increased by 8% while the consultant workforce grew by only 4.7%.

Market Driver

The integration of artificial intelligence and machine learning into imaging workflows is revolutionizing the Global Diagnostic Imaging Market by improving diagnostic accuracy and operational efficiency. These technologies are becoming essential for mitigating workforce shortages by automating routine image analysis, optimizing scan protocols, and prioritizing urgent cases for review. Regulatory approvals for these sophisticated algorithms are accelerating; according to the U.S. Food and Drug Administration, the cumulative number of authorized AI and ML-enabled medical devices reached 950 in August 2024, with radiology applications comprising 76% of these approvals. By streamlining workflows and reducing scan times, AI integration enhances patient throughput and maximizes the utility of existing imaging infrastructure.

Market growth is further propelled by increasing government and private investments in healthcare infrastructure, aimed at clearing post-pandemic backlogs and modernizing aging equipment. Public sector initiatives are allocating substantial funds to procure advanced diagnostic tools, thereby decentralizing care and improving accessibility. For example, the UK Government allocated £1.5 billion in its October 2024 Autumn Budget to expand diagnostic capabilities, including the deployment of modern scanners and the establishment of new surgical hubs. These investments are generating robust financial performance for major industry players; Siemens Healthineers reported a 7.7% comparable revenue growth for its Imaging segment in November 2024, highlighting the sustained global demand for advanced diagnostic systems.

Market Challenge

The shortage of trained radiologists and technicians presents a structural barrier that fundamentally limits the scalability of the global diagnostic imaging market. Although the rising prevalence of chronic diseases creates a theoretical demand for higher procedure volumes, healthcare providers are unable to fully convert this into market growth due to the scarcity of human expertise. Diagnostic equipment cannot generate value without qualified personnel to operate it and interpret results, effectively placing a hard ceiling on operational throughput. Consequently, facilities are often forced to delay acquiring new technologies, diverting capital budgets toward premium labor costs rather than expanding diagnostic capabilities.

This operational strain significantly impedes the market's trajectory by causing systemic inefficiencies. In 2024, the Royal College of Radiologists indicated that 97% of radiology departments were compelled to rely on expensive outsourcing or insourcing measures to manage unmanageable reporting workloads. This heavy dependence on external support suggests that the market has reached a saturation point where existing staffing levels cannot support organic growth. As healthcare systems struggle to manage these bottlenecks, the deployment of additional imaging infrastructure is stalled, directly hampering the broader expansion potential of the market.

Market Trends

The market is increasingly prioritizing sustainable and eco-friendly imaging solutions, driven by the urgent need to reduce the environmental impact of energy-intensive modalities like MRI and CT. Manufacturers are engineering systems that minimize power consumption and reduce dependency on scarce resources such as helium, which is critical for cooling conventional magnets. This shift is both regulatory and operational, as healthcare facilities seek to lower long-term running costs and protect against supply chain volatilities. According to a March 2025 report by Royal Philips, their BlueSeal magnet technology has collectively saved over 2.75 million liters of helium since 2018, illustrating the rapid adoption of helium-free infrastructure.

Simultaneously, the proliferation of portable and point-of-care devices is democratizing diagnostic access, moving imaging beyond traditional hospital suites into diverse clinical settings. Advancements in semiconductor technology have enabled the development of handheld ultrasound units that offer high-resolution imaging at a fraction of the size and cost of cart-based systems. This trend facilitates immediate bedside diagnosis, reducing patient wait times and alleviating the burden on central radiology departments. In May 2025, Butterfly Network reported a 20% year-over-year revenue growth in its first-quarter financial results, underscoring the surging global demand for agile, handheld imaging solutions.

Key Market Players

• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Hitachi High-Tech Corporation
• Hologic, Inc.
• Siemens Healthineers AG
• Samsung Medicine Co., Ltd.
• Shimadzu Corporation
• Toshiba Medical Systems Corporation
• Esaote S.p.A
• Fujifilm Corporation

Report Scope

In this report, the Global Diagnostic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Imaging Market, By Product

• X-Ray
• Ultrasound
• Computed Tomography
• Nuclear Imaging
• Magnetic Resonance Imaging

Diagnostic Imaging Market, By Application

• Oncology
• Neurology
• Cardiology
• Gynecology
• Orthopedics
• Others

Diagnostic Imaging Market, By End Use

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Imaging Centers

Diagnostic Imaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Market.

Available Customizations:

Global Diagnostic Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (X-Ray, Ultrasound, Computed Tomography, Nuclear Imaging, Magnetic Resonance Imaging)
  • 5.2.2. By Application (Oncology, Neurology, Cardiology, Gynecology, Orthopedics, Others)
  • 5.2.3. By End Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Imaging Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Diagnostic Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diagnostic Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Diagnostic Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Diagnostic Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Diagnostic Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Diagnostic Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Diagnostic Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Diagnostic Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Diagnostic Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Diagnostic Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Diagnostic Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Diagnostic Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Diagnostic Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Diagnostic Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Diagnostic Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Diagnostic Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Diagnostic Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Diagnostic Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Diagnostic Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Diagnostic Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Diagnostic Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Diagnostic Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Diagnostic Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Diagnostic Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Diagnostic Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. GE HealthCare Technologies Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Koninklijke Philips N.V.
• 15.3. Hitachi High-Tech Corporation
• 15.4. Hologic, Inc.
• 15.5. Siemens Healthineers AG
• 15.6. Samsung Medicine Co., Ltd.
• 15.7. Shimadzu Corporation
• 15.8. Toshiba Medical Systems Corporation
• 15.9. Esaote S.p.A
• 15.10. Fujifilm Corporation

16. Strategic Recommendations

17. About Us & Disclaimer